SARA GIVENS: Open Payments
NPI 1679166128 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,070 in 99 payments from 22 companies in 2025. Trend: 2023 $3,315 · 2024 $3,761 · 2025 $6,070
Consulting: $3,125Food & beverage: $2,945
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 10 | $1,667 |
| Janssen Biotech, Inc. | 8 | $1,384 |
| Incyte Corporation | 3 | $1,175 |
| GENZYME CORPORATION | 8 | $278 |
| UCB, Inc. | 16 | $262 |
| PFIZER INC. | 9 | $204 |
| Regeneron Healthcare Solutions, Inc. | 7 | $164 |
| ABBVIE INC. | 10 | $146 |
| Lilly USA, LLC | 7 | $138 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $105 |
Products named: Zoryve, TREMFYA, DUPIXENT, Bimzelx, LITFULO, SKYRIZI, Opzelura, CIBINQO.
Industry payments across FL — which companies pay providers there.
